Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway

Jun Ding; Chuang Qi; Jinmao Li; Chuying Huang; Jiayao Zhang; Yong Zhang; Yi Li; Bin Fan

doi:10.12659/MSM.929255

04 August 2021 : Animal Research

Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway

Jun Ding^1ABCDEFG*, Chuang Qi^2BCDEF, Jinmao Li^1BCDF, Chuying Huang^2BCD, Jiayao Zhang^1BCF, Yong Zhang^1BC, Yi Li^1BCF, Bin Fan^1CF

DOI: 10.12659/MSM.929255

Med Sci Monit 2021; 27:e929255

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 2 Se-methylselenocysteine (MSC) treatment influenced the liver injury of the hepatocellular carcinoma rat model. Liver injury was determined using hematoxylin and eosin staining. The scale bars of 200 μm are illustrated in the images.

Back to the Article

Se-Methylselenocysteine Alleviates Liver Injury in Diethylnitrosamine (DEN)-Induced Hepatocellular Carcinoma Rat Model by Reducing Liver Enzymes, Inhibiting Angiogenesis, and Suppressing Nitric Oxide (NO)/Nitric Oxide Synthase (NOS) Signaling Pathway

Your Privacy